Tibsovo
Drug timelines are a Plus or Pro feature.
26 regulatory and trial events tracked for Tibsovo, covering 2018-07-20 to 2026-04-03. Get the full timeline:
Most recent: Clinical Trial Update: Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation [Phase 3]